Search research articles
Contact Us
Filters
Showing results (1-10 of 74) with videos related to
Page
of 8
Sort By:
Current Drug Targets
|
June 6, 2015
The Epidemiological, Mechanistic and Potential Clinical Role of Androgen Receptor (AR) in Urothelial Carcinoma
Maria T Bourlon, Thomas W Flaig
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 18, 2019
Caring for Our Trainees: Lessons From Around the World
Ranjana Srivastava, Deborah Mukherji, Maria T Bourlon
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
|
May 29, 2020
Oncofertility Knowledge Among Internal Medicine Residents in an Academic Center in Mexico
Haydeé C Verduzco-Aguirre, Alfonso Gulias-Herrero, Maria T Bourlon
JCO Global Oncology
|
April 23, 2026
Latin America Special Series Infographic
Maria T Bourlon, Alba Kihn-Alarcón, Paola I Valdez-Sandoval
Oncology (Williston Park, N.Y.)
|
May 17, 2021
Hand-Foot Skin Reaction Secondary to Sunitinib in a Patient With Metastatic Clear Cell Renal Cell Carcinoma
Karen Férez-Blando, Francisco Castro-Alonso, Judith Domínguez-Cherit, et al.
Oncology (Williston Park, N.Y.)
|
July 10, 2020
Immune-Related Adverse Events Involving Multiple Organ Sites in a Patient Treated With Nivolumab Plus Ipilimumab
Yuly A Remolina-Bonilla, Brenda Jimenez-Franco, Elaine T Lam, et al.
Urologic Oncology
|
December 19, 2024
Impact of race and payor status on patterns of utilization of partial and radical nephrectomy in patients with renal cell carcinoma in California
Regina Barragan-Carrillo, Nicholas Salgia, Karyn S Eilber, et al.
Cancer Medicine
|
October 21, 2016
Clinical significance of sunitinib-associated macrocytosis in metastatic renal cell carcinoma
Maria T Bourlon, Dexiang Gao, Sara Trigero, et al.
International Journal of Dermatology
|
April 19, 2021
Do we need skin toxicity? Association of immune checkpoint inhibitor and tyrosine kinase inhibitor-related cutaneous adverse events with outcomes in metastatic renal cell carcinoma
Eduardo Corona-Rodarte, Antonio Olivas-Martínez, Yuly A Remolina-Bonilla, et al.
Frontiers in Oncology
|
July 18, 2022
Patterns of Treatment and Outcomes in Older Men With Penile Cancer: A SEER Dataset Analysis
Maria T Bourlon, Haydee Verduzco-Aguirre, Elizabeth Molina, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 74) with videos related to
Sort By:
Page
of 8
Current Drug Targets
|
June 6, 2015
The Epidemiological, Mechanistic and Potential Clinical Role of Androgen Receptor (AR) in Urothelial Carcinoma
Maria T Bourlon, Thomas W Flaig
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 18, 2019
Caring for Our Trainees: Lessons From Around the World
Ranjana Srivastava, Deborah Mukherji, Maria T Bourlon
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
|
May 29, 2020
Oncofertility Knowledge Among Internal Medicine Residents in an Academic Center in Mexico
Haydeé C Verduzco-Aguirre, Alfonso Gulias-Herrero, Maria T Bourlon
JCO Global Oncology
|
April 23, 2026
Latin America Special Series Infographic
Maria T Bourlon, Alba Kihn-Alarcón, Paola I Valdez-Sandoval
Oncology (Williston Park, N.Y.)
|
May 17, 2021
Hand-Foot Skin Reaction Secondary to Sunitinib in a Patient With Metastatic Clear Cell Renal Cell Carcinoma
Karen Férez-Blando, Francisco Castro-Alonso, Judith Domínguez-Cherit, et al.
Oncology (Williston Park, N.Y.)
|
July 10, 2020
Immune-Related Adverse Events Involving Multiple Organ Sites in a Patient Treated With Nivolumab Plus Ipilimumab
Yuly A Remolina-Bonilla, Brenda Jimenez-Franco, Elaine T Lam, et al.
Urologic Oncology
|
December 19, 2024
Impact of race and payor status on patterns of utilization of partial and radical nephrectomy in patients with renal cell carcinoma in California
Regina Barragan-Carrillo, Nicholas Salgia, Karyn S Eilber, et al.
Cancer Medicine
|
October 21, 2016
Clinical significance of sunitinib-associated macrocytosis in metastatic renal cell carcinoma
Maria T Bourlon, Dexiang Gao, Sara Trigero, et al.
International Journal of Dermatology
|
April 19, 2021
Do we need skin toxicity? Association of immune checkpoint inhibitor and tyrosine kinase inhibitor-related cutaneous adverse events with outcomes in metastatic renal cell carcinoma
Eduardo Corona-Rodarte, Antonio Olivas-Martínez, Yuly A Remolina-Bonilla, et al.
Frontiers in Oncology
|
July 18, 2022
Patterns of Treatment and Outcomes in Older Men With Penile Cancer: A SEER Dataset Analysis
Maria T Bourlon, Haydee Verduzco-Aguirre, Elizabeth Molina, et al.
Page
of 8